David Johnston

All filings by David Johnston on record concern Nektar Therapeutics. The record holds 3 filings, for trades running from 3 March 2006 to 14 May 2007.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 15 May 2007, the filings show a share grant worth €15 in Nektar Therapeutics. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.